Stericycle, Inc. (NASDAQ:SRCL - Get Free Report)'s stock price hit a new 52-week high on Friday . The stock traded as high as $61.97 and last traded at $61.97, with a volume of 443940 shares trading hands. The stock had previously closed at $61.47.
Analyst Upgrades and Downgrades
Separately, StockNews.com started coverage on Stericycle in a research report on Sunday, October 27th. They set a "hold" rating on the stock. One analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $74.00.
View Our Latest Report on SRCL
Stericycle Stock Performance
The stock has a market cap of $5.75 billion, a P/E ratio of 161.76, a PEG ratio of 3.36 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.13 and a quick ratio of 1.13. The firm's 50-day moving average price is $60.76 and its 200-day moving average price is $56.62.
Institutional Trading of Stericycle
Institutional investors and hedge funds have recently made changes to their positions in the company. Clearstead Trust LLC acquired a new stake in Stericycle in the 1st quarter valued at $25,000. International Assets Investment Management LLC purchased a new stake in shares of Stericycle during the 2nd quarter valued at approximately $45,000. Headlands Technologies LLC acquired a new position in shares of Stericycle in the 1st quarter valued at $44,000. Quest Partners LLC boosted its stake in Stericycle by 4,172.7% during the second quarter. Quest Partners LLC now owns 940 shares of the business services provider's stock worth $55,000 after buying an additional 918 shares during the period. Finally, Summit Securities Group LLC purchased a new position in shares of Stericycle during the 2nd quarter worth approximately $58,000. 98.82% of the stock is currently owned by institutional investors.
Stericycle Company Profile
(
Get Free Report)
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
Further Reading
Before you consider Stericycle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stericycle wasn't on the list.
While Stericycle currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
